| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,070 |
13,755 |
$3.09M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,983 |
9,657 |
$2.04M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,653 |
2,881 |
$1.63M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,253 |
5,809 |
$1.25M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,193 |
1,900 |
$578K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,738 |
3,213 |
$556K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,581 |
1,861 |
$520K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
19,027 |
13,460 |
$475K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,687 |
1,460 |
$445K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,860 |
3,350 |
$264K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
621 |
399 |
$201K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
22,860 |
12,301 |
$180K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,287 |
920 |
$163K |
| 71046 |
Radiologic examination, chest; 2 views |
4,068 |
3,581 |
$114K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,365 |
964 |
$101K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,229 |
1,945 |
$83K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,081 |
6,026 |
$72K |
| 20610 |
|
2,820 |
1,042 |
$70K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,068 |
1,699 |
$67K |
| 80053 |
Comprehensive metabolic panel |
9,955 |
8,130 |
$55K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
152 |
142 |
$55K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
482 |
425 |
$55K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
172 |
134 |
$53K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
910 |
817 |
$52K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,693 |
1,558 |
$52K |
| 73630 |
|
1,793 |
1,467 |
$52K |
| 97161 |
|
1,216 |
1,006 |
$47K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,774 |
8,682 |
$45K |
| 87631 |
|
512 |
455 |
$43K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
678 |
584 |
$41K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
170 |
138 |
$40K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,946 |
723 |
$39K |
| 73562 |
|
1,145 |
938 |
$38K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,800 |
7,167 |
$37K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
134 |
116 |
$34K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
487 |
445 |
$33K |
| 73030 |
|
1,034 |
868 |
$31K |
| 99215 |
Prolong outpt/office vis |
3,148 |
1,869 |
$30K |
| 84484 |
|
4,893 |
3,536 |
$28K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,097 |
932 |
$26K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,578 |
6,309 |
$22K |
| 83605 |
|
3,713 |
2,842 |
$21K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
96 |
85 |
$19K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
660 |
306 |
$18K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,083 |
3,058 |
$17K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
927 |
801 |
$16K |
| 72100 |
|
412 |
350 |
$16K |
| 73130 |
|
611 |
481 |
$15K |
| 84703 |
|
2,347 |
2,000 |
$15K |
| 11721 |
|
1,454 |
653 |
$15K |
| 86140 |
|
4,865 |
4,018 |
$14K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
24 |
14 |
$14K |
| 73610 |
|
597 |
510 |
$14K |
| 85027 |
|
5,970 |
5,078 |
$13K |
| 73502 |
|
462 |
379 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,221 |
2,793 |
$12K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
154 |
140 |
$12K |
| 83690 |
|
2,807 |
2,341 |
$12K |
| 81001 |
|
4,945 |
4,161 |
$12K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
187 |
174 |
$12K |
| 83735 |
|
3,899 |
3,113 |
$11K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
759 |
587 |
$11K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
465 |
229 |
$11K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
279 |
110 |
$11K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,038 |
3,325 |
$10K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
60 |
50 |
$10K |
| 83880 |
|
896 |
768 |
$10K |
| 73110 |
|
345 |
288 |
$10K |
| 71045 |
Radiologic examination, chest; single view |
3,000 |
2,579 |
$10K |
| 87040 |
|
1,670 |
805 |
$8K |
| 74018 |
|
208 |
185 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,189 |
1,906 |
$8K |
| 85379 |
|
1,376 |
1,183 |
$8K |
| 82077 |
|
1,041 |
854 |
$8K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
289 |
73 |
$6K |
| 82962 |
|
5,241 |
1,320 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
22,941 |
16,855 |
$6K |
| 85610 |
|
4,800 |
3,063 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
349 |
323 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
16 |
13 |
$5K |
| 84145 |
|
426 |
364 |
$4K |
| 81003 |
|
2,648 |
2,301 |
$4K |
| 87632 |
|
35 |
30 |
$4K |
| 93971 |
|
39 |
38 |
$4K |
| 87077 |
|
1,327 |
969 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
178 |
128 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,923 |
2,508 |
$4K |
| 80061 |
Lipid panel |
2,069 |
1,784 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
418 |
187 |
$4K |
| Q3014 |
Telehealth originating site facility fee |
1,283 |
965 |
$3K |
| 87186 |
|
1,104 |
862 |
$3K |
| 99443 |
|
191 |
166 |
$3K |
| 90715 |
|
205 |
168 |
$3K |
| 0240U |
|
169 |
115 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
375 |
305 |
$3K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
60 |
56 |
$2K |
| 90834 |
Psychotherapy, 45 minutes with patient |
123 |
50 |
$2K |
| 97162 |
|
56 |
48 |
$2K |
| 0011A |
|
124 |
98 |
$2K |
| 82248 |
|
857 |
746 |
$2K |
| 87081 |
|
146 |
135 |
$2K |
| 90686 |
|
785 |
643 |
$2K |
| 87420 |
|
35 |
33 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,376 |
1,104 |
$2K |
| 99442 |
|
160 |
144 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
913 |
698 |
$1K |
| 91320 |
|
287 |
265 |
$1K |
| 76830 |
Ultrasound, transvaginal |
15 |
12 |
$1K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
128 |
98 |
$1K |
| 0012A |
|
66 |
54 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
582 |
236 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,702 |
2,999 |
$1K |
| 92015 |
Determination of refractive state |
723 |
615 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
45 |
37 |
$903.29 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
45 |
37 |
$823.95 |
| 99310 |
Prolong nursin fac eval 15m |
34 |
29 |
$809.92 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,710 |
3,152 |
$742.89 |
| G0378 |
Hospital observation service, per hour |
89 |
61 |
$576.57 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,518 |
2,876 |
$567.55 |
| 88142 |
|
28 |
26 |
$534.24 |
| 99490 |
Ccm add 20min |
261 |
246 |
$511.05 |
| 90480 |
|
287 |
265 |
$491.09 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
480 |
379 |
$474.01 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
36 |
28 |
$445.63 |
| 91301 |
|
60 |
46 |
$414.93 |
| 97035 |
|
41 |
13 |
$390.54 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
208 |
169 |
$378.43 |
| 0071A |
|
17 |
15 |
$374.08 |
| J2704 |
Injection, propofol, 10 mg |
907 |
744 |
$295.77 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
95 |
76 |
$267.26 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,926 |
2,422 |
$245.36 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
175 |
150 |
$244.54 |
| 80047 |
|
39 |
35 |
$235.55 |
| 0001A |
|
26 |
14 |
$230.33 |
| 87510 |
|
14 |
13 |
$187.23 |
| 87480 |
|
14 |
13 |
$187.23 |
| 87660 |
|
14 |
13 |
$187.23 |
| 82043 |
|
115 |
97 |
$183.06 |
| 80143 |
|
18 |
12 |
$180.12 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,295 |
3,344 |
$169.95 |
| 90656 |
|
85 |
82 |
$167.51 |
| 90694 |
|
124 |
88 |
$167.31 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,578 |
2,119 |
$161.22 |
| 84100 |
|
101 |
78 |
$150.81 |
| 80179 |
|
17 |
12 |
$150.00 |
| 82728 |
|
14 |
12 |
$125.99 |
| 0064A |
|
160 |
129 |
$122.41 |
| 90677 |
|
16 |
12 |
$104.55 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
335 |
245 |
$103.54 |
| 0352U |
|
12 |
12 |
$100.56 |
| 85652 |
|
89 |
75 |
$89.96 |
| G0008 |
Administration of influenza virus vaccine |
1,227 |
1,083 |
$85.16 |
| 96127 |
|
39 |
27 |
$82.08 |
| 90662 |
|
418 |
361 |
$81.26 |
| 0124A |
|
192 |
155 |
$77.66 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
364 |
315 |
$65.39 |
| 82607 |
|
29 |
24 |
$64.94 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
62 |
53 |
$55.47 |
| 99406 |
|
43 |
17 |
$46.64 |
| 90653 |
|
64 |
59 |
$39.13 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
303 |
240 |
$38.75 |
| 96376 |
|
143 |
103 |
$34.43 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
445 |
312 |
$31.04 |
| 82565 |
|
51 |
40 |
$30.75 |
| 82550 |
|
15 |
13 |
$29.88 |
| G2058 |
Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). |
19 |
15 |
$20.61 |
| 84439 |
|
13 |
12 |
$18.64 |
| 0054A |
|
37 |
32 |
$9.44 |
| 99497 |
|
23 |
22 |
$5.64 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
130 |
104 |
$3.61 |
| 85018 |
|
42 |
37 |
$3.34 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
512 |
369 |
$2.29 |
| A9270 |
Non-covered item or service |
10,906 |
1,960 |
$1.68 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
81 |
53 |
$0.52 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
725 |
621 |
$0.46 |
| J3490 |
Unclassified drugs |
43 |
39 |
$0.43 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
60 |
56 |
$0.38 |
| G0009 |
Administration of pneumococcal vaccine |
32 |
31 |
$0.00 |
| 90732 |
|
13 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
39 |
34 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
12 |
12 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
14 |
12 |
$0.00 |
| 91306 |
|
18 |
12 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
18 |
14 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
198 |
163 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
31 |
28 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
115 |
80 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
14 |
13 |
$0.00 |